These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30404037)

  • 1. Obliterative Portal Venopathy Without Cirrhosis Is Prevalent in Pediatric Cystic Fibrosis Liver Disease With Portal Hypertension.
    Wu H; Vu M; Dhingra S; Ackah R; Goss JA; Rana A; Quintanilla N; Patel K; Leung DH
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2134-2136. PubMed ID: 30404037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
    Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-cirrhotic portal hypertension (obliterative portal venopathy) is the predominant form of chronic liver disease in cystic fibrosis.
    ONeill JP; Clifford CS; Nolan NP; McCormick PA
    Ir J Med Sci; 2023 Aug; 192(4):1657-1660. PubMed ID: 36114932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation in adult cystic fibrosis: Clinical, imaging, and pathological evidence of obliterative portal venopathy.
    Hillaire S; Cazals-Hatem D; Bruno O; de Miranda S; Grenet D; Poté N; Soubrane O; Erlinger S; Lacaille F; Mellot F; Vilgrain V; Paradis V
    Liver Transpl; 2017 Oct; 23(10):1342-1347. PubMed ID: 28816015
    [No Abstract]   [Full Text] [Related]  

  • 5. Features of Severe Liver Disease With Portal Hypertension in Patients With Cystic Fibrosis.
    Stonebraker JR; Ooi CY; Pace RG; Corvol H; Knowles MR; Durie PR; Ling SC
    Clin Gastroenterol Hepatol; 2016 Aug; 14(8):1207-1215.e3. PubMed ID: 27062904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SERPINA1 Z allele is associated with cystic fibrosis liver disease.
    Boëlle PY; Debray D; Guillot L; Corvol H;
    Genet Med; 2019 Sep; 21(9):2151-2155. PubMed ID: 30739910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging clinical perspectives in cystic fibrosis liver disease.
    Athwal VS; Scott JA; Fitzpatrick E; Rowland M
    Curr Opin Pulm Med; 2021 Nov; 27(6):593-599. PubMed ID: 34482340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study.
    Dajti E; Ravaioli F; Paiola G; Volpi S; Colecchia L; Ferrarese A; Alemanni LV; Cusumano C; Di Biase AR; Marasco G; Vestito A; Festi D; Rautou PE; Cipolli M; Colecchia A
    Liver Int; 2023 Nov; 43(11):2492-2502. PubMed ID: 37724776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obliterative portal venopathy without portal hypertension: an underestimated condition.
    Guido M; Sarcognato S; Sonzogni A; Lucà MG; Senzolo M; Fagiuoli S; Ferrarese A; Pizzi M; Giacomelli L; Colloredo G
    Liver Int; 2016 Mar; 36(3):454-60. PubMed ID: 26264219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of idiopathic non-cirrhotic portal hypertension.
    Guido M; Sarcognato S; Sacchi D; Colloredo G
    Virchows Arch; 2018 Jul; 473(1):23-31. PubMed ID: 29644430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies.
    Dana J; Debray D; Beaufrère A; Hillaire S; Fabre M; Reinhold C; Baumert TF; Berteloot L; Vilgrain V
    J Hepatol; 2022 Feb; 76(2):420-434. PubMed ID: 34678405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the novel gene FOPV are associated with familial autosomal dominant and non-familial obliterative portal venopathy.
    Besmond C; Valla D; Hubert L; Poirier K; Grosse B; Guettier C; Bernard O; Gonzales E; Jacquemin E
    Liver Int; 2018 Feb; 38(2):358-364. PubMed ID: 28792652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic portal venopathy and related disorders of the liver.
    Chawla Y; Dhiman RK
    Semin Liver Dis; 2008 Aug; 28(3):270-81. PubMed ID: 18814080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obliterative portal venopathy of the liver. Associated with so-called idiopathic portal hypertension or tropical splenomegaly.
    Nayak NC; Ramalingaswami V
    Arch Pathol; 1969 Apr; 87(4):359-69. PubMed ID: 5766763
    [No Abstract]   [Full Text] [Related]  

  • 15. Idiopathic noncirrhotic portal hypertension.
    Fiel MI; Schiano TD
    Semin Diagn Pathol; 2019 Nov; 36(6):395-403. PubMed ID: 31405536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic modifiers of liver disease in cystic fibrosis.
    Bartlett JR; Friedman KJ; Ling SC; Pace RG; Bell SC; Bourke B; Castaldo G; Castellani C; Cipolli M; Colombo C; Colombo JL; Debray D; Fernandez A; Lacaille F; Macek M; Rowland M; Salvatore F; Taylor CJ; Wainwright C; Wilschanski M; Zemková D; Hannah WB; Phillips MJ; Corey M; Zielenski J; Dorfman R; Wang Y; Zou F; Silverman LM; Drumm ML; Wright FA; Lange EM; Durie PR; Knowles MR;
    JAMA; 2009 Sep; 302(10):1076-83. PubMed ID: 19738092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multidisciplinary Approach to Pretransplant and Posttransplant Management of Cystic Fibrosis-Associated Liver Disease.
    Freeman AJ; Sellers ZM; Mazariegos G; Kelly A; Saiman L; Mallory G; Ling SC; Narkewicz MR; Leung DH
    Liver Transpl; 2019 Apr; 25(4):640-657. PubMed ID: 30697907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
    Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
    PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic Manifestations of Cystic Fibrosis.
    Sakiani S; Kleiner DE; Heller T; Koh C
    Clin Liver Dis; 2019 May; 23(2):263-277. PubMed ID: 30947876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obliteration of portal venules contributes to portal hypertension in biliary cirrhosis.
    Shan S; Zhao X; Wood-Trageser MA; Hu D; Liu L; Qi B; Jian J; Wang P; Lv W; Hu C
    J Pathol; 2024 Jun; 263(2):178-189. PubMed ID: 38551075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.